Pressure BioSciences Inc (PBIO)
0.115
0.00 (0.00%)
USD |
OTCM |
Jun 25, 16:00
Pressure BioSciences Enterprise Value: 26.84M for June 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 24, 2024 | 26.84M |
| June 21, 2024 | 27.36M |
| June 20, 2024 | 27.68M |
| June 18, 2024 | 27.71M |
| June 17, 2024 | 27.74M |
| June 14, 2024 | 27.87M |
| June 13, 2024 | 27.67M |
| June 12, 2024 | 27.30M |
| June 11, 2024 | 28.13M |
| June 10, 2024 | 28.14M |
| June 07, 2024 | 28.60M |
| June 06, 2024 | 28.93M |
| June 05, 2024 | 30.28M |
| June 04, 2024 | 29.39M |
| June 03, 2024 | 29.91M |
| May 31, 2024 | 30.81M |
| May 30, 2024 | 31.52M |
| May 29, 2024 | 30.18M |
| May 28, 2024 | 30.45M |
| May 24, 2024 | 30.63M |
| May 23, 2024 | 30.20M |
| May 22, 2024 | 29.96M |
| May 21, 2024 | 29.75M |
| May 20, 2024 | 31.13M |
| May 17, 2024 | 31.13M |
| Date | Value |
|---|---|
| May 16, 2024 | 31.16M |
| May 15, 2024 | 30.45M |
| May 14, 2024 | 30.45M |
| May 13, 2024 | 30.70M |
| May 10, 2024 | 31.20M |
| May 09, 2024 | 30.96M |
| May 08, 2024 | 30.81M |
| May 07, 2024 | 30.45M |
| May 06, 2024 | 29.75M |
| May 03, 2024 | 30.49M |
| May 02, 2024 | 31.52M |
| May 01, 2024 | 31.07M |
| April 30, 2024 | 31.11M |
| April 29, 2024 | 31.15M |
| April 26, 2024 | 30.70M |
| April 25, 2024 | 30.46M |
| April 24, 2024 | 30.81M |
| April 23, 2024 | 31.34M |
| April 22, 2024 | 31.34M |
| April 19, 2024 | 31.73M |
| April 18, 2024 | 32.22M |
| April 17, 2024 | 32.22M |
| April 16, 2024 | 31.52M |
| April 15, 2024 | 31.51M |
| April 12, 2024 | 33.16M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
8.274M
Minimum
Dec 18 2019
49.53M
Maximum
Jan 26 2023
25.53M
Average
28.99M
Median
Sep 14 2021
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 515.43M |
| Retractable Technologies Inc | -11.12M |
| Xtant Medical Holdings Inc | 104.19M |
| Asensus Surgical Inc | 80.25M |
| Catheter Precision Inc | 3.188M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.904M |
| Revenue (Quarterly) | 0.3124M |
| Total Expenses (Quarterly) | 3.804M |
| EPS Diluted (Quarterly) | -0.30 |
| Gross Profit Margin (Quarterly) | -6.78% |
| Profit Margin (Quarterly) | -3.17K% |
| Earnings Yield | -1.41K% |
| Normalized Earnings Yield | -1321.19 |